University of Oxford Department of Oncology
LightNews LightNews
banner
oncology.ox.ac.uk
University of Oxford Department of Oncology
@oncology.ox.ac.uk
620 followers 99 following 86 posts
Posts Replies Media Videos
oncology.ox.ac.uk
Celebrating some of the brilliant women in our team and the trailblazers who inspire them this International Day of Women and Girls in Science 👩‍🔬✨

Scroll through below ⬇️⬇️

#WomenInScience #InternationalDayOfWomenAndGirlsInScience
February 11, 2026 at 9:34 PM
Reposted by University of Oxford Department of Oncology
oxfordcancer.bsky.social
Aglaia Skolariki, 2nd year Clinical Research Training Fellow, is researching how abnormal cell division in aggressive cancers drives particular genetic changes. 👇#InternationalDayofWomenAndGirlsInScience2026
@medsci.ox.ac.uk @oncology.ox.ac.uk @oxcio.bsky.social

www.cancer.ox.ac.uk/news/interna...
February 11, 2026 at 12:20 PM
Reposted by University of Oxford Department of Oncology
oxfordcancer.bsky.social
Our second annual Oesophagogastric Cancer Centre of Excellence Symposium will examine how recent advancements in research and clinical practice are contributing to improved patient outcomes.

✅Open to @ox.ac.uk researchers

📆March 6th, 9am to 5pm

Register 👇

www.eventbrite.co.uk/e/oesophagog...
Oesophagogastric Cancer Centre of Excellence 2026 Symposium
An event focused on advancing scientific collaboration and improving treatments for oesophagogastric cancer.
www.eventbrite.co.uk
February 9, 2026 at 2:53 PM
oncology.ox.ac.uk
Every cancer is different. Every patient is unique.

On #WorldCancerDay2026, meet the researchers helping shape more individualised cancer care.

#UnitedByUnique
February 4, 2026 at 3:38 PM
Reposted by University of Oxford Department of Oncology
imm.ox.ac.uk
#ScientistSpotlight 🧪

This week we’re featuring Robert Watson, an Academic Clinical Lecturer in the Department of Oncology, University of Oxford.

@ox.ac.uk @oncology.ox.ac.uk @medsci.ox.ac.uk
February 3, 2026 at 9:55 AM
oncology.ox.ac.uk
🆕Study launched to investigate whether insulin levels influence how women with the most common type of breast cancer respond to treatment.

Trans-EndoNET will examine the relationship between insulin levels & response to aromatise inhibitors in women with ER+HER2- breast cancer.
New clinical study launched examining the role of insulin in breast cancer treatment response
A new clinical study has launched to investigate whether insulin levels influence how women with the most common type of breast cancer respond to treatment.
www.oncology.ox.ac.uk
January 30, 2026 at 11:22 AM
Reposted by University of Oxford Department of Oncology
octooxford.bsky.social
The LFS UK 2025 conference took place last September, updating on studies from across the country, including MILI.

Visit LFS UK 2025 to see the various presentations and update on the MILI trial tinyurl.com/d2dfm36x

#TP53 #LiFraumeniSyndrome #LFS @oncology.ox.ac.uk @oxfordcancer.bsky.social
January 29, 2026 at 2:31 PM
oncology.ox.ac.uk
Researchers from the Jiang Group have published Phase Ia trial results for OVM-200, a novel cancer vaccine targeting survivin.

The first-in-human trial, published in eClinicalMedicine, reports promising early safety & immunogenicity findings in patients with advanced solid tumours.

buff.ly/ZLCqaGC
OVM-200: Phase Ia Results of Novel Survivin Cancer Vaccine
Researchers from the Jiang Group in the Department of Oncology have published Phase Ia clinical trial results for OVM-200, a novel cancer vaccine targeting survivin. The first-in-human trial,…
www.oncology.ox.ac.uk
January 28, 2026 at 10:34 AM
Reposted by University of Oxford Department of Oncology
oxfordcancer.bsky.social
The Oxford Centre for Cancer Early Detection and Prevention (OxCODE) Funding Scheme is open!

🔎Pump-priming cancer early detection and prevention research

🧪Open to @ox.ac.uk researchers

💷£20K 1-year awards

📆Deadline: Fri 27 Feb

More on the OxCODE website 👇

www.oxcode.ox.ac.uk/about/oxcode....
January 14, 2026 at 10:41 AM
oncology.ox.ac.uk
2025 in numbers.

A year of research, teaching, and collaboration.
January 14, 2026 at 1:21 PM
oncology.ox.ac.uk
TrustedMDT is a multi-agent AI system designed to support cancer treatment planning.

The tool is made up of three agents, integrated into Microsoft teams, that work in concert to summarise clinical records, determine disease stage & draft evidence-based treatment recommendations.

@medsci.ox.ac.uk
January 7, 2026 at 11:36 AM
Reposted by University of Oxford Department of Oncology
eileenparkes.bsky.social
Parkes lab pre-print alert! ‘TMEM33 deletion potentiates anti-tumor CD8⁺ T cell immunity.’ Led by mtjackson101.bsky.social. Full bluetutorial follows! 1/10 www.biorxiv.org/content/10.6...
January 5, 2026 at 3:30 PM
oncology.ox.ac.uk
New Vacancy: Postdoctoral Researcher in Bioinformatics & Human Tissue Modelling

We have an exciting opportunity to join the O'Neill lab, contributing to a pioneering tissue-focused research programme aimed at enhancing cure rates for gastrointestinal cancers.

www.oncology.ox.ac.uk/about-us/wor...
December 19, 2025 at 1:45 PM
Reposted by University of Oxford Department of Oncology
ox.ac.uk
NEW: Oxford researchers have developed TrustedMDT, a multi-agent artificial intelligence (AI) system designed to support medical specialists during cancer treatment planning meetings.

Find out more ⬇️
Oxford-built multi-agent assistant for cancer care to be piloted in
Researchers at the University of Oxford have developed TrustedMDT, a multi-agent artificial intelligence (AI) system designed to support medical specialists during cancer treatment planning meetings.
www.ox.ac.uk
December 17, 2025 at 11:54 AM
oncology.ox.ac.uk
Congratulations to Kendra Perez-Smith, Translational Support Unit Manager, who has received an Outstanding Contribution to Sustainability Award for her innovation & leadership in establishing Lab QuTe: a department-wide network designed to reduce the environmental impact of clinical trials.
Kendra Perez-Smith receives Outstanding Contribution to Sustainability Award
The Department of Oncology is proud to share that Kendra Perez-Smith, Translational Support Unit (TSU) Manager, has received an Outstanding Contribution to Sustainability Award in recognition of her i...
www.oncology.ox.ac.uk
December 17, 2025 at 12:53 PM
oncology.ox.ac.uk
Researchers at @oncology.ox.ac.uk have developed TrustedMDT, a multi-agent AI system designed to support cancer treatment planning.

TrustedMDT is made up of three AI agents that work in concert to summarise clinical records, determine disease stage & draft treatment recommendations.

Read more ⬇️
Oxford-Built Multi-Agent assistant for Cancer Care to be piloted in collaboration with Microsoft
Researchers at the Department of Oncology have developed TrustedMDT, a multi-agent artificial intelligence (AI) system designed to support medical specialists during cancer treatment planning meetings...
www.oncology.ox.ac.uk
December 16, 2025 at 11:47 AM
oncology.ox.ac.uk
Congratulations to Keaton Jones who has received a @wellcometrust.bsky.social Early Career Award 🔬

The funding will enable Keaton & his team to shed light on immunotherapy resistance in pancreatic cancer, a critical hurdle that, if overcome, could provide much needed new treatment options.
New Study to Investigate How Immunometabolism Shapes Treatment Responses in Pancreatic Cancer
www.oncology.ox.ac.uk
December 8, 2025 at 1:11 PM
Reposted by University of Oxford Department of Oncology
octooxford.bsky.social
Congratulations to the team at Brighton and Sussex for recruiting 61 participants to SCOOT. @uhsussex.bsky.social @chestconsultant.bsky.social @oncology.ox.ac.uk

#lungcancer #personalisedtherapy and #earlydiagnosis
December 1, 2025 at 2:04 PM
Reposted by University of Oxford Department of Oncology
oxfordcancer.bsky.social
In case you missed it!

Sarah Blagden @oncology.ox.ac.uk featured in Channel 4’s Cancer Detectives: Finding the Cures last week, sharing ground-breaking precision-prevention research at Oxford!

Read more ⬇️

@sarahblagden.bsky.social @medsci.ox.ac.uk

www.cancer.ox.ac.uk/news/profess...
Professor Sarah Blagden shares cutting-edge precision prevention research at Oxford in new Channel 4 Documentary
Over the past year, Professor Blagden has been filming for Cancer Detectives: Finding the Cures, a new three-part documentary series from Channel 4 which follows three scientists on the front lines of...
www.cancer.ox.ac.uk
November 25, 2025 at 10:39 AM
Reposted by University of Oxford Department of Oncology
oxfordcancer.bsky.social
Oxford Professor Sarah Blagden, @oncology.ox.ac.uk appears in the first episode of Cancer Detectives: Finding the Cures on @Channel4 tonight!

📺 Watch at 9pm, Thurs 20 Nov, or stream on Channel 4.

Brought to you by @CR_UK.

#CancerDetectives #CancerPrevention

www.channel4.com/programmes/c...
Cancer Detectives: Finding the Cures
Three trailblazing scientists take on cancer, changing peoples’ lives, right now
www.channel4.com
November 20, 2025 at 11:47 AM
Reposted by University of Oxford Department of Oncology
cancerresearchuk.org
We’re thrilled to partner with Channel 4 on ‘Cancer Detectives: Finding the Cures’ - a new series which is shining a light on three trailblazing scientists taking on cancer, and explores how their work is changing patients’ lives right now. 👇 1/2
November 20, 2025 at 9:37 AM
oncology.ox.ac.uk
World’s first lung cancer prevention vaccine gets £2 million for clinical trial

People at high risk of lung cancer will soon be able to receive the experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial.

@medsci.ox.ac.uk @oxfordcancer.bsky.social
World’s first lung cancer prevention vaccine gets £2 million for clinical trial
People at high risk of lung cancer will soon be able to receive the first-ever experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. The LungVax vaccine ca...
www.oncology.ox.ac.uk
November 17, 2025 at 2:58 PM
Reposted by University of Oxford Department of Oncology
octooxford.bsky.social
Next up in the Meet The MILI Team series, is Dr Schaida Schirwani.

Dr Schirwani is a genetics consultant and is part of the MILI team at University Hospital Southampton.

#LFS #LiFraumeni @uhsft.bsky.social @oncology.ox.ac.uk
@oxfordcancer.bsky.social

tp53.co.uk/lfs-tp53/
November 13, 2025 at 1:23 PM
Reposted by University of Oxford Department of Oncology
oxfordcancer.bsky.social
What if we could stop #Cancer before it even starts?

Prof. Sarah Blagden @oncology.ox.ac.uk & PPI contributor Anna Fry discuss novel cancer prevention research on the @oxfordsparks.bsky.social podcast.

🎧 www.oxfordsparks.ox.ac.uk/podcasts/cou...

@sarahblagden.bsky.social @medsci.ox.ac.uk
November 12, 2025 at 1:02 PM
oncology.ox.ac.uk
INTREPID is one of five interdisciplinary teams launched
as part of a new UK initiative to transform disease research through the development of advanced human tissue models.

The team will evaluate & optimise the use of patient-derived explants as tumour models.

Learn more:
Oxford joins £15.9m national initiative to transform cancer research
Oxford scientists are part of a new £15.9 million UK initiative to transform disease research through the development of advanced human tissue models. The INTREPID project will evaluate and optimise
www.ox.ac.uk
November 12, 2025 at 10:00 AM